Agilon Health Inc Stock Price, News & Analysis

agilon health (NYSE: AGL), a company focused on transforming healthcare through physician empowerment, has announced the date for its third quarter 2024 financial results release. The results will be disclosed after market close on Thursday, November 7, 2024, followed by a conference call at 4:30 PM Eastern Time on the same day.

Interested parties can join the conference call by dialing (833) 470-1428 (U.S. participants) or +1 (404) 975-4839 (international participants) and using the participant code 520026. A simultaneous webcast will be available on the company's Investor Relations website. For those unable to attend live, a replay of the call will be accessible via webcast shortly after its conclusion.

agilon health (NYSE: AGL), a company focused on empowering physicians to transform community healthcare, has announced its participation in the 2024 Wells Fargo Healthcare Conference. The event will feature a fireside chat presentation by agilon health on Wednesday, September 4, at 3:00 PM Eastern Time.

Interested parties can access a live webcast of the presentation through the 'Events & Presentations' section of agilon's Investor Relations website. For those unable to attend the live event, a replay will be made available for on-demand viewing shortly after the presentation concludes.

This participation in a major healthcare conference underscores agilon health's commitment to engaging with investors and industry professionals, potentially providing insights into the company's strategies and outlook in the evolving healthcare landscape.

agilon health (NYSE: AGL) reported Q2 2024 results with revenue increasing 39% to $1.5 billion and Medicare Advantage membership growing 38% to 513,000. Total members on the agilon platform reached 645,000, up 40%. The company maintained its 2024 Medical Margin and Adjusted EBITDA guidance despite retroactive membership adjustments due to contract terminations. Key financials include:

- Gross profit: $32 million (down from $55 million in Q2 2023)
- Net loss: $31 million (increased from $17 million in Q2 2023)
- Medical margin: $106 million (down from $134 million in Q2 2023)
- Adjusted EBITDA: $3 million loss (compared to $12 million earnings in Q2 2023)

agilon is making progress on its performance action plan, focusing on refining payor relationships, increasing PCP engagement, improving data visibility, and accelerating operating efficiency.

agilon health (NYSE: AGL), a company focused on empowering physicians to transform healthcare, has announced its plans to release second quarter 2024 financial results. The results will be disclosed after the market closes on Tuesday, August 6, 2024, followed by a conference call at 4:30 PM Eastern Time to discuss the outcomes. Interested parties can access the call via phone or webcast, with details provided for both U.S. and international participants. A replay of the call will be made available on the company's Investor Relations website for on-demand listening after the event concludes.

agilon health announced the appointment of Karthik Rao, M.D., as its permanent Chief Medical Officer (CMO), effective immediately. Dr. Rao has been serving as interim CMO since February 2024 and was previously senior medical director and vice president of network performance at agilon. With nearly a decade of experience as a practicing internal medicine physician, Dr. Rao will co-lead clinical strategy and oversee clinical programs alongside Chief Clinical Officer Kevin Spencer, M.D., who brings over 25 years of experience in value-based care. Both will report to CEO Steve Sell and aim to enhance provider performance across agilon's Physician Network.

agilon health (NYSE: AGL) has appointed Jeff Schwaneke as its new Chief Financial Officer (CFO) and Executive Vice President, effective July 1, 2024. Schwaneke, who brings over 27 years of finance and operational experience, will transition from his current role as Executive Vice President at Centene He will succeed Timothy Bensley, who is retiring but will assist during the transition. Schwaneke will step down from agilon’s board, where he has served since 2022. His extensive background includes significant roles at Centene, where he contributed to revenue growth from $20 billion to $125 billion. Schwaneke holds a Bachelor's degree in Accounting from the University of Missouri and is a CPA (inactive).

agilon health (NYSE: AGL) will participate in the 44th Annual William Blair Growth Stock Conference with a presentation scheduled on June 5 at 12:20 PM Eastern Time. Interested parties can access a live webcast via the “Events & Presentations” section of agilon’s Investor Relations website, with a replay available for on-demand listening after the event.

Agilon health reported strong financial and operational results for the first quarter of 2024, with revenue increasing by 52% to $1.6 billion and Medicare Advantage membership growing by 43% to 523,000. The company continues to focus on driving profitability and enhancing operating efficiency while maintaining its full-year guidance for Medical Margin and Adjusted EBITDA. Agilon health is making progress on its performance action plan to improve performance and support growth in Adjusted EBITDA in 2024 and beyond. The company also announced new partnerships with leading physician groups, expanding its presence in several states. With a solid capital position and positive outlook for the fiscal year, agilon health is poised for continued success.

agilon health (AGL) has announced new physician partnerships with five leading practices to transition to a full-risk, value-based care model. This expansion will include over 3,000 primary care physicians reaching 700,000 senior patients in 30+ communities. The partnerships will enhance the quality of care for senior patients and further agilon's mission of transforming healthcare delivery.